Barrington, RI, United States of America

Douglas C Hixson


Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 102(Granted Patents)


Location History:

  • Barrington, RI (US) (1994 - 2011)
  • Boulder, CO (US) (2020)

Company Filing History:


Years Active: 1994-2020

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Douglas C Hixson

Introduction

Douglas C Hixson is a notable inventor based in Barrington, RI (US). He has made significant contributions to the field of therapeutic proteins, holding a total of 5 patents. His work focuses on the development and purification of inter-alpha inhibitor proteins, which have important applications in treating various human diseases.

Latest Patents

One of Hixson's latest patents is centered on the preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use. This invention relates to inter-alpha inhibitor proteins (IαIp) and outlines processes for purifying IαIp compositions. The therapeutic applications of these proteins include treatment for human diseases such as sepsis, septic shock, rheumatoid arthritis, cancer, and infectious diseases.

Career Highlights

Throughout his career, Hixson has worked with reputable organizations, including Rhode Island Hospital and Prothera Biologics, Inc. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Hixson has collaborated with esteemed colleagues, including Yow-Pin Lim and Djuro Josic. These partnerships have further enriched his research and innovation efforts in the field of therapeutic proteins.

Conclusion

Douglas C Hixson's contributions to the field of therapeutic proteins demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of research in developing treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…